Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 145.901% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.20 | - | - |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.70 | €30.00 | 104.082% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €122.00 | €135.22 | 10.835% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €91.08 | €99.50 | 9.245% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €45.13 | €41.65 | -7.717% |
| Cocrystal Pharma Inc. | 7 | 0 | 1 | 0 | €1.71 | €9.25 | 441.170% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €36.80 | €51.25 | 39.255% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €98.36 | - | - |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.67 | - | - |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.84 | €15.58 | -1.609% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.90 | €6.45 | 240.327% |
| Virbac S.A. | 1 | 0 | 0 | 0 | €358.50 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €44.40 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.72 | €5.00 | 5.932% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.71 | €10.00 | 29.702% |
| Icon plc | 18 | 0 | 3 | 0 | €293.10 | €319.67 | 9.065% |
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.71 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 13 | 1 | 2 | 1 | €15.60 | €18.51 | 18.641% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €211.00 | €294.01 | 39.342% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €288.00 | €297.31 | 3.233% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.80 | - | - |